Appeals Court Rejects False Claims Approach To FDA Off-Label Cases
Executive Summary
A ruling from the First Circuit suggests that plaintiffs can’t prove manufacturers violated the False Claims Act by suggesting FDA submissions were fraudulent, if FDA itself hasn’t taken any action against the manufacturer.